will continue promoting an effective pharmaceutical policy that contributes to
improve the health of the population, ensuring access to safe, quality and low
cost medicines, said Minister of Health, Doctor Mercedes Juan in the
inauguration of the X International Meeting of Leaders of Sanitary Agencies.
Dr. Mercedes Juan
also highlighted the strategy of regulation of the pharmaceutical sector, which
has reduced up to 61 percent, the cost of medicines in this country.
As an example, she
mentioned the liberation of 32 active substances, which belong to 357 generic
medicines that represent about 71 percent of death causes in Mexico.
In relation to
innovative medicines, Mexico´s Minister of Health, highlighted the
establishment of a regulatory cooperation plan between the different health
agencies, with the purpose to make more efficient the entry of medicines into this
She noted that as a
result of the innovation policy in the last three years, have been issued 150
authorizations to market medicines in the 20 most important therapeutic
classes, to attend the epidemiology of Mexico.
Dr. Mercedes Juan
stressed the importance of the international cooperation to establish the best
health regulations that benefit the patient in the access to medical products
for quality, safety and efficacy.
The Tenth International
Meeting of Leaders of Sanitary Agencies, brought together more than 50
countries of the five continents, including the United States, China, Japan,
Brazil, European Union, Canada, Australia, South Korea, and for the first time
were included, India, Russia, Spain and El Salvador.
The Commissioner of
the Federal Commission Against Sanitary Risks, Dr. Mikel Arriola, said that
Mexico broke the record of attendance at health summits which confirms Mexico´s
ability of convocation, and its leadership in Latin America.
He said that Mexico
obtained in China the headquarters unanimously, due to the improvements made by
the health agency to its regulatory framework on medicines and vaccines, which
were recognized and the Pan-American Health Organization in 2012 and certified
by the WHO in 2014.
He explained that
in the three days of work of the health summit, will be reviewed the challenges
and opportunities of the global agenda on regulation of generic and
biotechnological medicines, the good manufacturing practices for medicines, the
models of pharmacovigilance and how to strengthen national health agencies.
Arriola said that this type meetings pretend to benefit patients in Mexico and
the world, through the cooperation and regulatory convergence, allowing easy
access to more and better therapies with lower costs.
In the welcoming
the leaders of the health agencies, the undersecretary for Multilateral Affairs
and Human Rights, Miguel Ruiz Cabañas, stressed that the Mexican government
continues working for universal health coverage and the expansion of the access
of the Mexican population to the best medical products.
Follow us on Twitter: @SSalud_mx y @_MJuan_